Oxford Nanopore Technologies plc Share Price

Equities

ONT

GB00BP6S8Z30

Advanced Medical Equipment & Technology

Market Closed - London S.E. 16:35:01 26/04/2024 BST 5-day change 1st Jan Change
96.9 GBX +4.08% Intraday chart for Oxford Nanopore Technologies plc +4.47% -53.46%

Financials

Sales 2023 170M 212M 16.97B Sales 2024 * 189M 236M 18.91B Capitalization 833M 1.04B 83.33B
Net income 2023 -155M -194M -15.5B Net income 2024 * -149M -186M -14.9B EV / Sales 2023 9.19 x
Net cash position 2023 228M 285M 22.84B Net cash position 2024 * 313M 391M 31.29B EV / Sales 2024 * 2.75 x
P/E ratio 2023
-11 x
P/E ratio 2024 *
-5.74 x
Employees 1,238
Yield 2023 *
-
Yield 2024 *
-
Free-Float 69.93%
More Fundamentals * Assessed data
Dynamic Chart
1 day+4.08%
1 week+4.47%
Current month-20.25%
1 month-22.04%
3 months-32.94%
6 months-51.23%
Current year-53.46%
More quotes
1 week
91.24
Extreme 91.243
103.70
1 month
91.24
Extreme 91.243
127.00
Current year
91.24
Extreme 91.243
212.59
1 year
91.24
Extreme 91.243
279.00
3 years
91.24
Extreme 91.243
736.00
5 years
91.24
Extreme 91.243
736.00
10 years
91.24
Extreme 91.243
736.00
More quotes
Managers TitleAgeSince
Founder - 31/12/04
Director of Finance/CFO 42 01-21
Chief Investment Officer - 31/12/18
Members of the board TitleAgeSince
Director/Board Member 66 23/06/21
Director/Board Member 58 12-18
Chairman 59 31/07/22
More insiders
Date Price Change Volume
26/04/24 96.9 +4.08% 1,191,178
25/04/24 93.1 -9.26% 2,720,929
24/04/24 102.6 +0.10% 1,731,295
23/04/24 102.5 +6.49% 973,898
22/04/24 96.25 +3.77% 2,297,731

Delayed Quote London S.E., April 26, 2024 at 04:35 pm

More quotes
Oxford Nanopore Technologies plc is engaged in the generation of molecular sensing technology based on nanopores. The Company has developed a deoxyribonucleic (DNA)/ ribonucleic acid (RNA) sequencing technology. The Company’s segments include Life Science Research Tools, which offers products and services for research use, and COVID Testing, which provides products for SAR-Cov-2 testing. Its sequencing technology offers real-time analysis, in fully scalable formats from pocket to population scale, that can analyze native DNA or RNA and sequence any length of fragment to achieve short to ultra-long read lengths. Its products include MinION, GridION, PromethION, Flongle and others. MinION is a real-time device for DNA and RNA sequencing. GridION is a benchtop device designed to run and analyze up to five MinION or Flongle Flow Cells. Flongle is an adapter for MinION or GridION that enables direct, real-time DNA sequencing, or cDNA sequencing on smaller, single-use flow cells.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
0.969 GBP
Average target price
2.02 GBP
Spread / Average Target
+108.46%
Consensus